NC
Nilesh Champaklal Shah
About Nilesh Champaklal Shah
Data last updated:
Nilesh Champaklal Shah is a Director at Insat Pharma Private Limited (since 2022). The companies operate in Pharma. Insat Pharma Private Limited reported revenue of ₹63.58 Cr (FY 2023). Earlier, Nilesh Champaklal Shah was a Director at Meek Pharma Private Limited (2005–2024) and Designated Partner at Vermed Pharmaceuticals Llp (from 2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Insat Pharma Private Limited U24230GJ2022PTC129967 | Director | 09 Mar 2022 | 2022 | ₹63.58 Cr (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Meek Pharma Private Limited U24230UR2005PTC000876 | Director | 01 Aug 2005 | 2005 | ₹7.27 Cr (FY 2025) | Active |
| Vermed Pharmaceuticals Llp AAL-9424 | Designated Partner | 07 Feb 2018 | 2018 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nilesh Champaklal Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Brijesh Bhupendra Patel | 09623771 | Insat Pharma Private Limited | Director |
| Hardik Ravindrabhai Patel | 00357469 | Insat Pharma Private Limited | Director |
| Kruti Viral Shah | 09464207 | Insat Pharma Private Limited | Director |
| Lal Lachhmandas Hingorani | 01785030 | Insat Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nilesh Champaklal Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nilesh Champaklal Shah
Nilesh Champaklal Shah currently holds 1 directorship: Insat Pharma Private Limited (Director, since 09 Mar 2022, revenue ₹63.58 Cr (FY 2023)).
Nilesh Champaklal Shah was first appointed on 01 Aug 2005 as Director at Meek Pharma Private Limited. The most recent appointment on record is 09 Mar 2022 at Insat Pharma Private Limited.
Nilesh Champaklal Shah held 2 earlier board appointments: Meek Pharma Private Limited (Director, 01 Aug 2005 to 12 Jul 2024); Vermed Pharmaceuticals Llp (Designated Partner, from 07 Feb 2018).
The current boards of Nilesh Champaklal Shah's companies include Brijesh Bhupendra Patel (Insat Pharma Private Limited), Hardik Ravindrabhai Patel (Insat Pharma Private Limited), Kruti Viral Shah (Insat Pharma Private Limited), Lal Lachhmandas Hingorani (Insat Pharma Private Limited).